NCT04802356 2026-03-05Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma PatientsPETHEMA FoundationPhase 2 Active not recruiting50 enrolled
NCT05556798 2026-02-24A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After TreatmentMemorial Sloan Kettering Cancer CenterPhase 1 Active not recruiting9 enrolled